| Extended antithrombotic/antiplatelet therapy options | |||
|---|---|---|---|
| Medication | Trial | Dose | Indication |
| Clopidogrel | DAPT | 75 mg per day | Post-angioplasty tolerant to DAPT for 1 year |
| Prasugrel | DAPT | 10 mg per day (5 mg if weight < 60 kg or age > 75 years) | Post-angioplasty tolerant to DAPT for 1 year |
| Ticagrelor | PEGASUS-Tl MI-54 | 60 mg twice/day | Post-infarction with increased ischemic risk |
| Rivaroxabana | COMPASS | 2,5mg 2 vezes/ dia | Pacientes coronariopatas ou com doenga arterial periferica com alto risco trombotico |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.